Exit for the Munich-based startup Medineering: The company, which specializes in medical robotics, is being acquired by Brainlab AG. Hightech Gründerfonds and other investors are selling their shares. Details of the transaction have been agreed to remain confidential.
The High-Tech Gründerfonds (HTGF), Bavaria Capital, Born2grow, and two business angels participated in Medineering's seed financing round in the summer of 2014. In 2016, the eventual buyer, Brainlab, joined the investor group as part of a Series A round.
“A true success story”
Medineering was founded in 2014 by Dr. Stephan Nowatschin and Dr. Maximilian Krinninger. The company was the world's first to develop a modular "surgical robotics platform" designed to support and relieve surgeons during minimally invasive operations. The robotic assistance systems developed and now marketed since its founding are currently used primarily in the ENT field, but are expected to be applied in other fields in the future.
Ulrike Kalapis, Investment Manager at High-Tech Gründerfonds, says:
"Medineering is a true success story. In just a few years, the team has developed a sophisticated, innovative product and has now launched it. We are pleased to have been able to contribute to advancing the startup together with the visionary founding team through close support and intensive exchange."
Medineering founder Stephan Nowatschin says he and his team are very grateful to the seed investors:
“They enabled us to develop our prototypes and supported and advised us at every stage.”
